NEUREN PHARMACEUTICALS LIMITED - Announcements

1.31%

$17.78

Market Cap $2.240B

Healthcare Biotechnology

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

MEMPHASYS LIMITED

Many are concerned about global falling birthrates. This diverse stock has solutions. Here, then, one can’t afford to miss perusing what ASX-listed fertility tech healthcare smallcap Memphasys Ltd (ASX:MEM) can offer the world.

Announcements

Filter Results

All Price Sensitive Only

NEU	Notice under section 708A(5)(e) of the Corporations Act		20/04/11	59.86KB	Share
NEU	Appendix 3B		20/04/11	54.04KB	Share
NEU	Appendix 3B		20/04/11	54.42KB	Share
NEU	Annual Report to shareholders		31/03/11	538.46KB	Share
NEU	Appendix 3B		23/03/11	61.54KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		22/03/11	60.02KB	Share
NEU	Appendix 3B		21/03/11	54.5KB	Share
NEU	Appendix 3B		21/03/11	54.1KB	Share
NEU	Appendix 3B		21/03/11	54.61KB	Share
NEU	Results of Meeting		21/03/11	44.49KB	Share
NEU	Response to ASX Price Query	PRICE SENSITIVE	10/03/11	133.86KB	Share
NEU	Notice of Special Shareholders Meeting		03/03/11	149.72KB	Share
NEU	Preliminary Final Report	PRICE SENSITIVE	28/02/11	67.49KB	Share
NEU	Appendix 3B		21/02/11	61.74KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		18/02/11	59.8KB	Share
NEU	Appendix 3B		18/02/11	53.8KB	Share
NEU	Lapse of unquoted options		08/02/11	47.35KB	Share
NEU	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/11	82.43KB	Share
NEU	Appendix 3B		21/01/11	61.84KB	Share
NEU	Appendix 3B (amended)		21/01/11	113.95KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		19/01/11	57.82KB	Share
NEU	Appendix 3B		19/01/11	54.25KB	Share
NEU	Appendix 3B		19/01/11	53.92KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		20/12/10	59.26KB	Share
NEU	Securities Trading Policy		20/12/10	96.45KB	Share
NEU	Appendix 3B		20/12/10	53.69KB	Share
NEU	Appendix 3B		20/12/10	54.04KB	Share
NEU	Appendix 3B		22/11/10	61.32KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		19/11/10	59.88KB	Share
NEU	Appendix 3B		19/11/10	54.25KB	Share
NEU	Appendix 3B		19/11/10	53.54KB	Share
NEU	Neuren Initiates NNZ2566 Oral Formulation Development	PRICE SENSITIVE	18/11/10	44.72KB	Share
NEU	Neuren Completes Additional Phase I Study for TBI	PRICE SENSITIVE	16/11/10	50.33KB	Share
NEU	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/10	109.83KB	Share
NEU	Appendix 3B		27/10/10	77.52KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		20/10/10	61.42KB	Share
NEU	Appendix 3B		20/10/10	70.26KB	Share
NEU	Appendix 3B		20/10/10	69.5KB	Share
NEU	Lapse of unquoted options		07/10/10	48.61KB	Share
NEU	Appendix 3B		23/09/10	77.36KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		21/09/10	61.37KB	Share
NEU	Appendix 3B		21/09/10	69.54KB	Share
NEU	Appendix 3B		21/09/10	70.1KB	Share
NEU	Half Yearly Report and Accounts	PRICE SENSITIVE	26/08/10	395.4KB	Share
NEU	Appendix 3B		25/08/10	77.07KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		20/08/10	61.27KB	Share
NEU	Appendix 3B		20/08/10	69.18KB	Share
NEU	Appendix 3B		20/08/10	69.93KB	Share
NEU	Appendix 4C - quarterly	PRICE SENSITIVE	28/07/10	113.33KB	Share
NEU	Appendix 3B		23/07/10	76.52KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		21/07/10	61.48KB	Share
NEU	SpringTree becomes a substantial shareholder		21/07/10	151.92KB	Share
NEU	Appendix 3B		21/07/10	68.45KB	Share
NEU	Appendix 3B		21/07/10	69.11KB	Share
NEU	Appendix 3B		24/06/10	76.9KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		21/06/10	61.46KB	Share
NEU	Appendix 3B (options)		21/06/10	68.3KB	Share
NEU	Appendix 3B (shares)		21/06/10	69.15KB	Share
NEU	Appendix 3B		27/05/10	76.41KB	Share
NEU	Results of Meeting		25/05/10	32.27KB	Share
NEU	CEO Presentation to AGM		25/05/10	148.49KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		21/05/10	34.25KB	Share
NEU	Appendix 3B		21/05/10	70.14KB	Share
NEU	Appendix 3B		21/05/10	69.58KB	Share
NEU	Neuren Starts Phase II Trial of NNZ2566	PRICE SENSITIVE	06/05/10	39.74KB	Share
NEU	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/10	101.43KB	Share
NEU	Notice of Annual General Meeting/Proxy Form		27/04/10	211.94KB	Share
NEU	Appendix 3B (convertible note)		23/04/10	95.31KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		21/04/10	27.84KB	Share
NEU	Appendix 3B (options)		21/04/10	49.69KB	Share
NEU	Appendix 3B (shares)		21/04/10	49.31KB	Share
NEU	Lapse of unquoted options		06/04/10	42.04KB	Share
NEU	Annual Report to shareholders		30/03/10	379.03KB	Share
NEU	Appendix 3B - ESOP		25/03/10	91.08KB	Share
NEU	Appendix 3B (convertible note)		24/03/10	144.61KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		22/03/10	54.59KB	Share
NEU	Appendix 3B		22/03/10	136.41KB	Share
NEU	Appendix 3B		22/03/10	136.77KB	Share
NEU	Grant funding for TFF oncology program	PRICE SENSITIVE	19/03/10	66.4KB	Share
NEU	Trial of Second Neuren Drug Motiva to be Initiated	PRICE SENSITIVE	03/03/10	28.07KB	Share
NEU	Preliminary Final Report	PRICE SENSITIVE	26/02/10	200.8KB	Share
NEU	Appendix 3B (convertible note)		22/02/10	95.18KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		18/02/10	54.48KB	Share
NEU	Appendix 3B (shares)		18/02/10	135.98KB	Share
NEU	Appendix 3B (options)		18/02/10	136.3KB	Share
NEU	Ceasing to be a substantial holder		12/02/10	42.3KB	Share
NEU	Change in substantial holding		12/02/10	108.18KB	Share
NEU	Change in substantial holding		12/02/10	106.01KB	Share
NEU	Change in substantial holding		12/02/10	111.78KB	Share
NEU	Cato strategic partnership and appoints US CMO	PRICE SENSITIVE	11/02/10	27.13KB	Share
NEU	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/10	193.31KB	Share
NEU	Appendix 3B		20/01/10	115.16KB	Share
NEU	Change in substantial holding		13/01/10	209.75KB	Share
NEU	Change of Director's Interest Notice		24/12/09	27.66KB	Share
NEU	Notice under section 708A(5)(e) of the Corporations Act		23/12/09	54.56KB	Share
NEU	Appendix 3B (options)		23/12/09	88.54KB	Share
NEU	Appendix 3B (shares)		23/12/09	87.28KB	Share
NEU	Neuren Completes Shareholder Approved Funding		23/12/09	24.57KB	Share
NEU	Results of Special Shareholders Meeting		22/12/09	42.15KB	Share
NEU	Initial Director's Interest Notice		15/12/09	94.33KB	Share

NEUNotice under section 708A(5)(e) of the Corporations Act
20/04/11		59.86KB	Share
NEUAppendix 3B
20/04/11		54.04KB	Share
NEUAppendix 3B
20/04/11		54.42KB	Share
NEUAnnual Report to shareholders
31/03/11		538.46KB	Share
NEUAppendix 3B
23/03/11		61.54KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
22/03/11		60.02KB	Share
NEUAppendix 3B
21/03/11		54.5KB	Share
NEUAppendix 3B
21/03/11		54.1KB	Share
NEUAppendix 3B
21/03/11		54.61KB	Share
NEUResults of Meeting
21/03/11		44.49KB	Share
NEUResponse to ASX Price Query
10/03/11	PRICE SENSITIVE	133.86KB	Share
NEUNotice of Special Shareholders Meeting
03/03/11		149.72KB	Share
NEUPreliminary Final Report
28/02/11	PRICE SENSITIVE	67.49KB	Share
NEUAppendix 3B
21/02/11		61.74KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
18/02/11		59.8KB	Share
NEUAppendix 3B
18/02/11		53.8KB	Share
NEULapse of unquoted options
08/02/11		47.35KB	Share
NEUAppendix 4C - quarterly
31/01/11	PRICE SENSITIVE	82.43KB	Share
NEUAppendix 3B
21/01/11		61.84KB	Share
NEUAppendix 3B (amended)
21/01/11		113.95KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
19/01/11		57.82KB	Share
NEUAppendix 3B
19/01/11		54.25KB	Share
NEUAppendix 3B
19/01/11		53.92KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
20/12/10		59.26KB	Share
NEUSecurities Trading Policy
20/12/10		96.45KB	Share
NEUAppendix 3B
20/12/10		53.69KB	Share
NEUAppendix 3B
20/12/10		54.04KB	Share
NEUAppendix 3B
22/11/10		61.32KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
19/11/10		59.88KB	Share
NEUAppendix 3B
19/11/10		54.25KB	Share
NEUAppendix 3B
19/11/10		53.54KB	Share
NEUNeuren Initiates NNZ2566 Oral Formulation Development
18/11/10	PRICE SENSITIVE	44.72KB	Share
NEUNeuren Completes Additional Phase I Study for TBI
16/11/10	PRICE SENSITIVE	50.33KB	Share
NEUAppendix 4C - quarterly
27/10/10	PRICE SENSITIVE	109.83KB	Share
NEUAppendix 3B
27/10/10		77.52KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
20/10/10		61.42KB	Share
NEUAppendix 3B
20/10/10		70.26KB	Share
NEUAppendix 3B
20/10/10		69.5KB	Share
NEULapse of unquoted options
07/10/10		48.61KB	Share
NEUAppendix 3B
23/09/10		77.36KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
21/09/10		61.37KB	Share
NEUAppendix 3B
21/09/10		69.54KB	Share
NEUAppendix 3B
21/09/10		70.1KB	Share
NEUHalf Yearly Report and Accounts
26/08/10	PRICE SENSITIVE	395.4KB	Share
NEUAppendix 3B
25/08/10		77.07KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
20/08/10		61.27KB	Share
NEUAppendix 3B
20/08/10		69.18KB	Share
NEUAppendix 3B
20/08/10		69.93KB	Share
NEUAppendix 4C - quarterly
28/07/10	PRICE SENSITIVE	113.33KB	Share
NEUAppendix 3B
23/07/10		76.52KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
21/07/10		61.48KB	Share
NEUSpringTree becomes a substantial shareholder
21/07/10		151.92KB	Share
NEUAppendix 3B
21/07/10		68.45KB	Share
NEUAppendix 3B
21/07/10		69.11KB	Share
NEUAppendix 3B
24/06/10		76.9KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
21/06/10		61.46KB	Share
NEUAppendix 3B (options)
21/06/10		68.3KB	Share
NEUAppendix 3B (shares)
21/06/10		69.15KB	Share
NEUAppendix 3B
27/05/10		76.41KB	Share
NEUResults of Meeting
25/05/10		32.27KB	Share
NEUCEO Presentation to AGM
25/05/10		148.49KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
21/05/10		34.25KB	Share
NEUAppendix 3B
21/05/10		70.14KB	Share
NEUAppendix 3B
21/05/10		69.58KB	Share
NEUNeuren Starts Phase II Trial of NNZ2566
06/05/10	PRICE SENSITIVE	39.74KB	Share
NEUAppendix 4C - quarterly
30/04/10	PRICE SENSITIVE	101.43KB	Share
NEUNotice of Annual General Meeting/Proxy Form
27/04/10		211.94KB	Share
NEUAppendix 3B (convertible note)
23/04/10		95.31KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
21/04/10		27.84KB	Share
NEUAppendix 3B (options)
21/04/10		49.69KB	Share
NEUAppendix 3B (shares)
21/04/10		49.31KB	Share
NEULapse of unquoted options
06/04/10		42.04KB	Share
NEUAnnual Report to shareholders
30/03/10		379.03KB	Share
NEUAppendix 3B - ESOP
25/03/10		91.08KB	Share
NEUAppendix 3B (convertible note)
24/03/10		144.61KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
22/03/10		54.59KB	Share
NEUAppendix 3B
22/03/10		136.41KB	Share
NEUAppendix 3B
22/03/10		136.77KB	Share
NEUGrant funding for TFF oncology program
19/03/10	PRICE SENSITIVE	66.4KB	Share
NEUTrial of Second Neuren Drug Motiva to be Initiated
03/03/10	PRICE SENSITIVE	28.07KB	Share
NEUPreliminary Final Report
26/02/10	PRICE SENSITIVE	200.8KB	Share
NEUAppendix 3B (convertible note)
22/02/10		95.18KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
18/02/10		54.48KB	Share
NEUAppendix 3B (shares)
18/02/10		135.98KB	Share
NEUAppendix 3B (options)
18/02/10		136.3KB	Share
NEUCeasing to be a substantial holder
12/02/10		42.3KB	Share
NEUChange in substantial holding
12/02/10		108.18KB	Share
NEUChange in substantial holding
12/02/10		106.01KB	Share
NEUChange in substantial holding
12/02/10		111.78KB	Share
NEUCato strategic partnership and appoints US CMO
11/02/10	PRICE SENSITIVE	27.13KB	Share
NEUAppendix 4C - quarterly
29/01/10	PRICE SENSITIVE	193.31KB	Share
NEUAppendix 3B
20/01/10		115.16KB	Share
NEUChange in substantial holding
13/01/10		209.75KB	Share
NEUChange of Director's Interest Notice
24/12/09		27.66KB	Share
NEUNotice under section 708A(5)(e) of the Corporations Act
23/12/09		54.56KB	Share
NEUAppendix 3B (options)
23/12/09		88.54KB	Share
NEUAppendix 3B (shares)
23/12/09		87.28KB	Share
NEUNeuren Completes Shareholder Approved Funding
23/12/09		24.57KB	Share
NEUResults of Special Shareholders Meeting
22/12/09		42.15KB	Share
NEUInitial Director's Interest Notice
15/12/09		94.33KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $17.78		Change 0.230(1.31%)		Mkt cap ! $2.240B

Open	High	Low	Value	Volume
$17.83	$17.99	$17.35	$16.12M	911.8K

Buyers (Bids)

No.	Vol.	Price($)
2	11000	$17.40

Sellers (Offers)

Price($)	Vol.	No.
$17.80	10070	2

View Market Depth

No.	Vol.	Price($)
2	11000	17.400
2	2732	17.300
1	300	17.100
1	58	17.060
1	10	17.040

Price($)	Vol.	No.
17.800	70	1
17.940	566	1
17.990	73	1
18.000	4313	4
18.100	611	2

Last trade - 16.10pm 08/08/2025 (20 minute delay)

NEU (ASX) Chart

NEUREN PHARMACEUTICALS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories